European metals and materials sectors look for more EU support for battery industry

A consortium of European metals and materials companies has issued a joint letter urging the European Union (EU) to increase financial support for the bloc’s battery industry. They argue that the EU’s current plans and funds are insufficient to compete effectively with China and the United States in the battery sector, which is crucial for electric vehicles (EVs) and renewable energy storage.

In their letter to the European Commission, the companies emphasized that China controls significant shares of cleantech manufacturing and 50-90% of critical minerals processing capacity required for these technologies, making it a dominant player in the global supply chain.

The signatories of the letter include prominent firms such as mining company Rio Tinto, chemical group Solvay, and battery materials manufacturers Umicore and Northvolt. They called for the creation of a European Critical Minerals Fund, which would operate at the EU level and provide direct financing to companies involved in the battery industry.

Additionally, the companies urged the European Commission to expand its innovation fund to include targeted support for the critical minerals sector. They criticized existing EU funding streams as “a patchwork of insufficient, uncoordinated, and complex schemes” that mainly focus on research and development, lacking support for production scale-up and investment attraction.

The letter highlights the urgency of strengthening Europe’s battery industry to ensure the continent’s competitiveness in the transition to green technologies. It also underscores concerns about China’s dominance in the cleantech sector and the United States’ substantial investments under the Inflation Reduction Act.

The signatories argue that Europe’s investment climate has been further complicated by the ongoing conflict in Ukraine, making it imperative for the EU to take swift and decisive action to support its battery industry.

Elevate your business with QU4TRO PRO!

Gain access to comprehensive analysis, in-depth reports and market trends.

Interested in learning more?

Sign up for Top Insights Today

Top Insights Today delivers the latest insights straight to your inbox.

You will get daily industry insights on

Oil & Gas, Rare Earths & Commodities, Mining & Metals, EVs & Battery Technology, ESG & Renewable Energy, AI & Semiconductors, Aerospace & Defense, Sanctions & Regulation, Business & Politics.

By clicking subscribe you agree to our privacy and cookie policy and terms and conditions of use.

Read more insights

German Chancellor Scholz’s China visit overshadowed by Middle East tensions

German Chancellor Olaf Scholz’s three-day tour of China began against the backdrop of escalating tensions in the Middle East, particularly due to Iran’s recent attacks on Israel. Despite his agenda focusing on strengthening ties with Germany’s top trade partner and addressing trade issues, the conflict…

Greenland brinkmanship rattles allies, yet markets still trade the base case

Trump’s tariff threats against close allies are not just a trade story but a stress test of the political bargain that has underpinned Western security and commerce for decades.

The immediate market response of softer equity futures, higher implied yields, stronger gold, a weaker dollar versus the euro and sterling fits the classic pattern of a risk-off jolt mixed with a credibility premium being priced into U.S. policy.

U.S.-China tariff truce masks the bigger risk of Beijing’s grip on drug inputs

A brief thaw between Washington and Beijing has paused the tariff volleys for a year, but nothing in the underlying rivalry suggests a durable peace. The next time relations lurch, China still holds a potent lever it has barely touched: the pharmaceuticals supply chain.

Unlike soybeans or rare earth magnets, where Beijing has already flexed muscles, medicines and their chemical building blocks remain a largely untested chokepoint, with far higher stakes for U.S. public health and national security.

Stay informed

error: Content is protected !!